Clinical and Molecular Characteristics of Chinese Patients With X-Linked Lymphoproliferative Syndrome Type 1

被引:7
|
作者
An, Yun-Fei [1 ,2 ]
Luo, Xiao-Bo [1 ]
Yang, Xi [1 ]
Wang, Jing [1 ]
Li, Li [1 ]
Zhao, Xiao-Dong [1 ,2 ]
机构
[1] Chongqing Med Univ, Childrens Hosp, Key Lab Child Dev & Disorders, Minist Educ, Chongqing 400014, Peoples R China
[2] Chongqing Med Univ, Childrens Hosp, Div Immunol, Chongqing 400014, Peoples R China
基金
中国国家自然科学基金;
关键词
mild clinical phenotype; primary immunodeficiency; residual SAP expression; X-linked lymphoproliferative syndrome; BARR-VIRUS INFECTION; DISEASE GENE; LYMPHOCYTIC VASCULITIS; SH2D1A; SAP; IMMUNODEFICIENCY; DEFICIENCY; FAMILY; MUTATIONS; RESPONSES;
D O I
10.1002/pbc.25126
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundX-linked lymphoproliferative syndrome type 1 (XLP1) is a rare inherited, life-threatening immunodeficiency disorder caused by mutations in SH2D1A gene. It affect approximately two to three males per million. Fewer than 10 cases with definite gene mutations have been reported in Chinese mainland and no rapid diagnosis method has been established. ProcedureWe determined the clinical and molecular characteristics of five patients with XLP1. The SH2D1A gene were amplified by PCR and sequenced, the SAP expression was analyzed by flow cytometry. ResultsTwo patients had novel SH2D1A mutations and three had mutations that have been previously reported. Three patients presented with fulminant infectious mononucleosis or hemophagocytic lymphohistiocytosis and one presented with lymphoma. Null or decreased SAP expression on PBMCs was noted. The remaining patient presented with unique, recurrent, nonfulminant infectious mononucleosis and bimodal intracellular SAP protein expression. ConclusionsThe overall molecular characteristics and clinical phenotypes of Chinese patients with XLP1 matched previous reports. The unique bimodal intracellular SAP protein expression indicated the presence of some residual SAP-positive T cells that are able to respond to persistent Epstein-Barr virus infection and could explain the relatively mild clinical phenotype of this patient. Pediatr Blood Cancer 2014;61:2043-2047. (c) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:2043 / 2047
页数:5
相关论文
共 50 条
  • [21] Hemophagocytic lymphohistiocytosis secondary to X-linked lymphoproliferative syndrome type 2
    del Estal, Pedro Laguna
    Gomez, Amy Galan
    Prieto, Sonia Garcia
    MEDICINA CLINICA, 2021, 157 (04): : 207 - 208
  • [22] X-linked lymphoproliferative syndrome:: from clinical presentation to gene.
    Stéphan, JL
    ARCHIVES DE PEDIATRIE, 2000, 7 (11): : 1205 - 1211
  • [23] X-LINKED LYMPHOPROLIFERATIVE SYNDROME REGISTRY REPORT
    HAMILTON, JK
    PAQUIN, LA
    SULLIVAN, JL
    MAURER, HS
    CRUZI, FG
    PROVISOR, AJ
    STEUBER, CP
    HAWKINS, E
    YAWN, D
    CORNET, JA
    CLAUSEN, K
    FINKELSTEIN, GZ
    LANDING, B
    GRUNNET, M
    PURTILO, DT
    JOURNAL OF PEDIATRICS, 1980, 96 (04): : 669 - 673
  • [24] MAPPING THE LOCUS FOR X-LINKED LYMPHOPROLIFERATIVE SYNDROME
    SKARE, JC
    MILUNSKY, A
    BYRON, KS
    SULLIVAN, JL
    CLINICAL RESEARCH, 1986, 34 (02): : A508 - A508
  • [25] The abnormal gene in X-linked lymphoproliferative syndrome
    Sullivan, JL
    CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (04) : 431 - 434
  • [26] IMMUNOGLOBULIN THERAPY IN THE X-LINKED LYMPHOPROLIFERATIVE SYNDROME
    PURTILO, DT
    VOX SANGUINIS, 1987, 52 (1-2) : 165 - 165
  • [27] Expanding clinical spectrum of female X-linked lymphoproliferative syndrome 2
    Suryaprakash, Shruthi
    El-Baba, Mohammad
    Walkovich, Kelly J.
    Savasan, Sureyya
    PEDIATRIC BLOOD & CANCER, 2021, 68 (02)
  • [28] MAPPING THE LOCUS FOR X-LINKED LYMPHOPROLIFERATIVE SYNDROME
    SKARE, J
    MILUNSKY, A
    BYRON, KS
    SULLIVAN, JL
    PEDIATRIC RESEARCH, 1986, 20 (04) : A303 - A303
  • [29] CLINICAL FEATURES AND OUTCOME OF X-LINKED LYMPHOPROLIFERATIVE SYNDROME TYPE 1 (SAP DEFICIENCY) AND TYPE 2 (XIAP DEFICIENCY) IN JAPAN
    Kanegane, Hirokazu
    Yang, Xi
    Nishida, Naonori
    Ishii, Eiichi
    Miyawaki, Toshio
    PEDIATRIC BLOOD & CANCER, 2013, 60 (09) : E78 - E78
  • [30] Clinical and Molecular Characteristics of Immunodysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome in China
    An, Y-F.
    Xu, F.
    Wang, M.
    Zhang, Z-Y.
    Zhao, X-D.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2011, 74 (03) : 304 - 309